Free Trial

Encision Q4 2023 Earnings Report

$0.48 0.00 (0.00%)
As of 01/21/2025

Encision EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Encision Revenue Results

Actual Revenue
$1.81 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Encision Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Encision Earnings Headlines

Encision Inc (ECIA)
January 29th - the next big trading catalyst to watch
Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO the market… Unleashing more explosive moves than ever before.
See More Encision Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Encision? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Encision and other key companies, straight to your email.

About Encision

Encision (OTCMKTS:ECIA), a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.

View Encision Profile

More Earnings Resources from MarketBeat